INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Early diagnosis could be the key to vastly improving treatment for Alzheimer’s disease and most of the studies being ...

An ETH spin-off, Swiss Vascular, has developed anatomically exact silicone models of cerebral vessels. Through this ...

Slower walking speed could signal early cognitive decline. Gait may become a powerful, simple tool for detecting how fast ...

Australians are finding surgical cures for epilepsy in as little as two years, thanks to advancements in artificial ...